Evidence map›Paper›PMID 30799343›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males.

Yudai Koya, Tomohiro Suzuki, Mayumi Tai, Osamu Ichii, Nobuo Matsuhashi, Yutaka Ejiri, Masatsugu Miyazawa, Michihiko Shibata, Masaru Harada, Tsutomu Kumabe and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yudai KoyaThe Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan.
Tomohiro SuzukiDepartment of Gastroenterology, Fukushima Rosai Hospital, Japan.
Mayumi TaiDepartment of Gastroenterology, Fukushima Rosai Hospital, Japan.
Osamu IchiiDepartment of Gastroenterology, Fukushima Rosai Hospital, Japan.
Nobuo MatsuhashiDepartment of Gastroenterology, Fukushima Rosai Hospital, Japan.
Yutaka EjiriDepartment of Gastroenterology, Fukushima Rosai Hospital, Japan.
Masatsugu MiyazawaDepartment of Surgery, Fukushima Rosai Hospital, Japan.
Michihiko ShibataThe Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan.
Masaru HaradaThe Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan.
Tsutomu KumabeKumabe Clinic, Japan.
Osamu NakashimaDepartment of Clinical Laboratory Medicine, Kurume University Hospital, Japan.
University of Occupational and Environmental Health Japan · JPKurume University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two men (24 and 34 years of age) with a single hypervascular liver tumor were admitted to our hospital. The tumors were diagnosed as hepatocellular adenoma (HCA) by an ultrasound-guided biopsy and classified as inflammatory type by immunohistochemical staining. Considering the risk of malignant transformation, they underwent surgical resection. Although the serum levels of protein induced by vitamin K absence/antagonist-II (PIVKA-II) were slightly elevated, they normalized after the resection. The diagnosis of HCA including malignant transformation is often difficult by image findings alone. Careful immunohistochemical examinations are very useful for the diagnosis and classification of subgroups, including malignant transformation. In addition, we proved that HCA without malignant transformation expresses PIVKA-II.

Indexed as

Adenoma, Liver CellAdultBiomarkersBiomarkers, TumorHumansLiver NeoplasmsMaleProtein PrecursorsProthrombinacarboxyprothrombinBiomarkersBiomarkers, TumorProtein PrecursorsProthrombinbeta-catenin activationinflammatory hepatocellular adenomamalignant transformationprotein induced by vitamin K absence/antagonist-II

Identifiers

PMID30799343
PMCPMC6630141
OpenAlexW2915361404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.